> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Meeting on Generic Drug User Fees: Correction
- URL: https://www.fdaweb.com/public-meeting-on-generic-drug-user-fees-correction/
- Published: 2016-10-24T12:00:00.000Z
- Updated: 2026-09-14T21:41:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137147

*Federal Register* Notice: FDA has corrected a 9/26 notice announcing a public meeting to discuss proposed recommendations for reauthorizing the Generic Drug User Fee Amendments of 2012\. On page 66038, in the final paragraph of the first column, the second sentence is corrected to read: “Specifically, FDA would issue product-specific guidance identifying the methodology for developing drugs and generating evidence needed to support ANDA approval, for 90% of new chemical entity new drug applications that are approved on or after 10/1/2017, at least 2 years prior to the earliest lawful filing date.” Additionally, FDA extended the open comment period until 11/16\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-10-24/pdf/2016-25603.pdf?ref=fdaweb.com).